Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO‐ABLE study

BACKGROUND: Fixed combination calcipotriol 50 μg/g (Cal) plus betamethasone 0.5 mg/g (BD) foam has been developed as a new treatment option for patients with psoriasis. METHODS: The randomized, parallel‐group, investigator‐blinded Phase III, 12‐week PSO‐ABLE study compared the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, C., Stein Gold, L., Cambazard, F., Kalb, R.E., Lowson, D., Bang, B., Griffiths, C.E.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Psoriasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207928/
https://www.ncbi.nlm.nih.gov/pubmed/27531752
http://dx.doi.org/10.1111/jdv.13859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207928/
https://www.ncbi.nlm.nih.gov/pubmed/27531752
http://dx.doi.org/10.1111/jdv.13859

Ejemplares similares